Catalyst Pharmaceutical Partners Inc (CPRX.O)

CPRX.O on Consolidated Issue listed on NASDAQ Capital Market

0.88USD
24 May 2013
Price Change (% chg)

$0.04 (+5.38%)
Prev Close
$0.83
Open
$0.82
Day's High
$0.88
Day's Low
$0.82
Volume
175,045
Avg. Vol
741,557
52-wk High
$2.27
52-wk Low
$0.37

CPRX.O

Chart for CPRX.O

About

Catalyst Pharmaceutical Partners, Inc. is a development-stage biopharmaceutical company. The Company is focused on the development and commercialization of prescription drugs targeting addiction diseases and disorders of the central nervous system with a focus on the treatment of addiction and epilepsy. As of December 31, 2011,... (more)

Overall

Beta: 0.95
Market Cap (Mil.): $36.45
Shares Outstanding (Mil.): 41.42
Dividend: --
Yield (%): --

Financials

  CPRX.O Industry Sector
P/E (TTM): -- 46.63 34.30
EPS (TTM): -0.14 -- --
ROI: -39.66 1.55 18.43
ROE: -44.35 2.77 19.30
Search Stocks

Latest News about CPRX.O

U.S. women make slow progress into boardrooms, executive jobs

NEW YORK - Although women make up nearly half of the U.S. workforce, only 16.6 percent have seats on the boards of Fortune 500 companies and the number has barely budged since 2005, according to a study released on Tuesday.

11 Dec 2012
» More CPRX.O News

Competitors

  Price Change
Johnson & Johnson (JNJ.N) $86.82 -0.39
Merck & Co., Inc. (MRK.N) $47.16 -0.17
Roche Holding Ltd. (ROG.VX) CHF253.10 +2.40
Abbott Laboratories (ABT.N) $37.76 +0.28
Bayer AG (BAYGn.DE) €84.46 +0.55
Bayer AG (BAYE.F) -- --
Eli Lilly & Co. (LLY.N) $54.14 -0.60
Bristol Myers Squibb Co. (BMY.N) $47.40 +0.40
Bristol Myers Squibb Co. (BMY_p.N) $567.60 0.00
Amgen, Inc. (AMGN.OQ) $105.91 +0.29

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Catalyst Pharmaceutical Ptnrs
Provider: S&P Capital IQ Quantitative Report
$35.00
Buy
COMPSCRIPT INC (CPRX) 12-months forecast
Provider: Pechala's Reports
$15.00
Buy
Catalyst Pharmaceutical Partners Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
Thomson Reuters Stock Report - CATALYST PHARMACEUTICAL PARTNERS INC (CPRX-O)
Provider: Thomson Reuters Stock Report
$25.00
Buy
CATALYST PHARMA (CPRX) Zacks Company Snapshot
Provider: Zacks Investment Research Inc.
$12.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research
Search Stocks